Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer02:18

Cancer

53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

14.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
14.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Metastasis02:30

Metastasis

6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
What is Cancer?02:12

What is Cancer?

14.0K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reinventing type 2 immunity in cancer.

Nature·2025
Same author

Contribution of initial lymphatics to oral wound healing after tooth extraction.

European journal of oral sciences·2024
Same author

Activation of ILC2s through constitutive IFNγ signaling reduction leads to spontaneous pulmonary fibrosis.

Nature communications·2023
Same author

Characterization of metabolic phenotypes and distinctive genes in mice with low-weight gain.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2023
Same author

Gut microbial carbohydrate metabolism contributes to insulin resistance.

Nature·2023
Same author

IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse.

Journal of immunology (Baltimore, Md. : 1950)·2022

Related Experiment Video

Updated: Jan 15, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.9K

Cancer in disguise: a parasite within.

Marek Wagner1, Shigeo Koyasu2,3

  • 1Innate Immunity Research Group, Life Sciences and Biotechnology Center, Łukasiewicz Research Network - PORT Polish Center for Technology Development, Wrocław, Poland. marek.wagner@port.lukasiewicz.gov.pl.

The EMBO Journal
|January 13, 2026
PubMed
Summary
This summary is machine-generated.

Cancer cells act like parasites, using host resources and evading immune responses. Understanding these parasitic strategies, particularly their interaction with type-2 immunity, offers new therapeutic avenues for cancer treatment.

Keywords:
AnthelminticsCancerParasitesTumor MicroenvironmentType-2 Immunity

More Related Videos

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting
05:34

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

33.7K
A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

9.9K

Related Experiment Videos

Last Updated: Jan 15, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.9K
A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting
05:34

A Cancer Cell Spheroid Assay to Assess Invasion in a 3D Setting

Published on: November 20, 2015

33.7K
A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
07:23

A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster

Published on: September 11, 2013

9.9K

Area of Science:

  • Oncology
  • Immunology
  • Parasitology

Background:

  • Cancer cells exhibit parasitic traits, mirroring helminth survival strategies.
  • Malignant cells co-opt evolutionarily conserved tactics for host persistence and immune evasion.
  • Cancer's exploitation of host resources parallels parasitic mechanisms.

Purpose of the Study:

  • To explore mechanistic parallels between cancer and helminth infections.
  • To investigate how cancer cells mimic parasitic survival strategies.
  • To understand the role of type-2 immunity in cancer-parasite interactions.

Main Methods:

  • Comparative analysis of cancer cell biology and helminthic parasitic strategies.
  • Review of literature on immune evasion and tissue remodeling in both contexts.
  • Exploration of type-2 immune responses in relation to cancer and parasitic infections.

Main Results:

  • Cancer cells employ parasitic tactics for immune evasion and tissue remodeling.
  • Malignant cells engage type-2 immune responses, similar to helminth infections.
  • Parallels suggest type-2 immunity's dual role in cancer, potentially tumoricidal.

Conclusions:

  • Viewing cancer as a parasitic process challenges traditional oncogenesis models.
  • Mechanistic insights from parasitology can inform novel cancer therapies.
  • Leveraging cancer's parasitic nature offers new therapeutic opportunities.